Skip to main navigation Skip to search Skip to main content

21st century excitatory amino acid research: A Q & A with Jeff Watkins and Dick Evans

  • Jeffrey C. Watkins
  • , Richard H. Evans
  • , Àlex Bayés
  • , Sam A. Booker
  • , Alasdair Gibb
  • , Angela M. Mabb
  • , Mark Mayer
  • , Jack R. Mellor
  • , Elek Molnár
  • , Li Niu
  • , Arturo Ortega
  • , Yuriy Pankratov
  • , David Ramos-Vicente
  • , Ada Rodríguez-Campuzano
  • , Antonio Rodríguez-Moreno
  • , Lu Yang Wang
  • , Yu Tian Wang
  • , Lonnie Wollmuth
  • , David J.A. Wyllie
  • , Min Zhuo
  • Bruno G. Frenguelli
  • Autonomous University of Barcelona
  • University of Edinburgh
  • University College London
  • Georgia State University
  • National Institutes of Health
  • University of Bristol
  • SUNY Albany
  • Centro de Investigacion y de Estudios Avanzados del Instituto Politécnico Nacional
  • University of Warwick
  • Universidad Pablo de Olavide
  • University of Toronto
  • University of British Columbia
  • Qingdao International Academician Park Research Institute

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In 1981 Jeff Watkins and Dick Evans wrote what was to become a seminal review on excitatory amino acids (EAAs) and their receptors (Watkins and Evans, 1981). Bringing together various lines of evidence dating back over several decades on: the distribution in the nervous system of putative amino acid neurotransmitters; enzymes involved in their production and metabolism; the uptake and release of amino acids; binding of EAAs to membranes; the pharmacological action of endogenous excitatory amino acids and their synthetic analogues, and notably the actions of antagonists for the excitations caused by both nerve stimulation and exogenous agonists, often using pharmacological tools developed by Jeff and his colleagues, they provided a compelling account for EAAs, especially L-glutamate, as a bona fide neurotransmitter in the nervous system. The rest, as they say, is history, but far from being consigned to history, EAA research is in rude health well into the 21st Century as this series of Special Issues of Neuropharmacology exemplifies. With EAAs and their receptors flourishing across a wide range of disciplines and clinical conditions, we enter into a dialogue with two of the most prominent and influential figures in the early days of EAA research: Jeff Watkins and Dick Evans.

Original languageEnglish
Article number108743
JournalNeuropharmacology
Volume198
DOIs
StatePublished - Oct 15 2021

Fingerprint

Dive into the research topics of '21st century excitatory amino acid research: A Q & A with Jeff Watkins and Dick Evans'. Together they form a unique fingerprint.

Cite this